Drug Shortage Report for LODALIS
Report ID | 163659 |
Drug Identification Number | 02432463 |
Brand name | LODALIS |
Common or Proper name | LODALIS |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | COLESEVELAM HYDROCHLORIDE |
Strength(s) | 3.75G |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 30ct |
ATC code | C10AC |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2022-10-31 |
Actual start date | |
Estimated end date | 2023-08-01 |
Actual end date | 2022-08-01 |
Shortage status | Avoided shortage |
Updated date | 2022-08-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-08-03 | French | Compare |
v3 | 2022-08-03 | English | Compare |
v2 | 2022-06-29 | French | Compare |
v1 | 2022-06-29 | English | Compare |
Showing 1 to 4 of 4